Toews Corporation’s Boston Scientific BSX Stock Holding History

Toews Corporation’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-14,700	Closed	-$776K	–	28
2023 Q3	$776K	Buy	+14,700	New	+$771K	0.47%	39

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Toews Corporation's BSX Position: Q4 2023 in Review

Toews Corporation sold out of Boston Scientific (BSX) in Q4 2023, closing a stake of 14,700 shares — an estimated $776K sold.

Toews Corporation first reported a position in BSX in Q3 2023 and held it in 1 quarter. The position peaked at $776K in Q3 2023. 1,148 funds tracked by Wall St. Rank hold BSX as of Q4 2023.

Toews Corporation reported no remaining Boston Scientific position as of Q4 2023 after selling out during the quarter.
Toews Corporation sold 14,700 Boston Scientific shares in Q4 2023, an estimated $776K.
Toews Corporation first reported a position in Boston Scientific in Q3 2023 and held it in 1 quarter.
Toews Corporation's Boston Scientific position peaked at $776K in Q3 2023.
1,148 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2023.

Based on Toews Corporation's 13F filing for Q4 2023, filed 17 Jan 2024.